Additional file 1: Table S1. of Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study
Thomas Bertelmann
Nicolas Feltgen
Martin Scheffler
Ulrich Hufenbach
Annette Wiedon
Helmut Wilhelm
Focke Ziemssen
10.6084/m9.figshare.c.3607322_D1.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Table_S1_of_Vision-related_quality_of_life_in_patients_receiving_intravitreal_ranibizumab_injections_in_routine_clinical_practice_baseline_data_from_the_German_OCEAN_study/4351370
Mean baseline NEI VFQ-25 composite scores and study periods for OCEAN (treatment-naĂŻve participants) and for pivotal clinical trials of ranibizumab, by indication (nAMD, DME, BRVO, CRVO). (DOCX 23 kb)
2016-09-20 05:00:00
Age-related macular degeneration
Diabetic macular edema
Retinal vein occlusion
Real-world evidence
Ranibizumab
OCEAN study
Anti-VEGF
Intravitreal injection
Visual acuity (VA)
Optical coherence tomography (OCT)